DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban)
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-12-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296221144044 |
_version_ | 1828118652027666432 |
---|---|
author | Rachel Ryu PharmD, BCPS |
author_facet | Rachel Ryu PharmD, BCPS |
author_sort | Rachel Ryu PharmD, BCPS |
collection | DOAJ |
first_indexed | 2024-04-11T13:35:53Z |
format | Article |
id | doaj.art-cb0e88d105ec45c78dbdb84f08f80348 |
institution | Directory Open Access Journal |
issn | 1938-2723 |
language | English |
last_indexed | 2024-04-11T13:35:53Z |
publishDate | 2022-12-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Clinical and Applied Thrombosis/Hemostasis |
spelling | doaj.art-cb0e88d105ec45c78dbdb84f08f803482022-12-22T04:21:32ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232022-12-012810.1177/10760296221144044DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban)Rachel Ryu PharmD, BCPShttps://doi.org/10.1177/10760296221144044 |
spellingShingle | Rachel Ryu PharmD, BCPS DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban) Clinical and Applied Thrombosis/Hemostasis |
title | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban) |
title_full | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban) |
title_fullStr | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban) |
title_full_unstemmed | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban) |
title_short | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban) |
title_sort | doacs in valvular heart disease latest key updates on proact xa apixaban and invictus rivaroxaban |
url | https://doi.org/10.1177/10760296221144044 |
work_keys_str_mv | AT rachelryupharmdbcps doacsinvalvularheartdiseaselatestkeyupdatesonproactxaapixabanandinvictusrivaroxaban |